These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 16452219
1. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. Andringa KK, Coleman MC, Aykin-Burns N, Hitchler MJ, Walsh SA, Domann FE, Spitz DR. Cancer Res; 2006 Feb 01; 66(3):1605-10. PubMed ID: 16452219 [Abstract] [Full Text] [Related]
2. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL, Gius D. Cancer Res; 2003 Jun 15; 63(12):3413-7. PubMed ID: 12810678 [Abstract] [Full Text] [Related]
3. 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, Li L, Spitz DR, Cullen JJ. Free Radic Biol Med; 2008 Feb 01; 44(3):322-31. PubMed ID: 18215740 [Abstract] [Full Text] [Related]
4. Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells. Lin T, Yang MS. Toxicology; 2007 Jun 03; 235(1-2):1-10. PubMed ID: 17416446 [Abstract] [Full Text] [Related]
5. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR. Cancer Res; 2007 Apr 01; 67(7):3364-70. PubMed ID: 17409446 [Abstract] [Full Text] [Related]
6. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress. Scarbrough PM, Mapuskar KA, Mattson DM, Gius D, Watson WH, Spitz DR. Free Radic Biol Med; 2012 Jan 15; 52(2):436-43. PubMed ID: 22100505 [Abstract] [Full Text] [Related]
7. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. Reliene R, Schiestl RH. Carcinogenesis; 2006 Feb 15; 27(2):240-4. PubMed ID: 16162646 [Abstract] [Full Text] [Related]
8. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis. Tanaka T, Uchiumi T, Kohno K, Tomonari A, Nishio K, Saijo N, Kondo T, Kuwano M. Biochem Biophys Res Commun; 1998 May 19; 246(2):398-403. PubMed ID: 9610371 [Abstract] [Full Text] [Related]
9. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies. Yamaguchi H, Kidachi Y, Kamiie K, Noshita T, Umetsu H, Fuke Y, Ryoyama K. Biochem Pharmacol; 2013 Aug 15; 86(4):458-68. PubMed ID: 23791871 [Abstract] [Full Text] [Related]
10. Glutathione depletion in human T lymphocytes: analysis of activation-associated gene expression and the stress response. Walsh AC, Michaud SG, Malossi JA, Lawrence DA. Toxicol Appl Pharmacol; 1995 Aug 15; 133(2):249-61. PubMed ID: 7645021 [Abstract] [Full Text] [Related]
11. Vitamin D is a prooxidant in breast cancer cells. Koren R, Hadari-Naor I, Zuck E, Rotem C, Liberman UA, Ravid A. Cancer Res; 2001 Feb 15; 61(4):1439-44. PubMed ID: 11245448 [Abstract] [Full Text] [Related]
14. 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells. Mustafa EH, Mahmoud HT, Al-Hudhud MY, Abdalla MY, Ahmad IM, Yasin SR, Elkarmi AZ, Tahtamouni LH. Asian Pac J Cancer Prev; 2015 Feb 15; 16(8):3213-22. PubMed ID: 25921122 [Abstract] [Full Text] [Related]
15. Upregulation of endogenous glutathione system by 3H-1,2-dithiole-3-thione in pancreatic RINm5F beta-cells as a novel strategy for protecting against oxidative beta-cell injury. Zhu H, Zhang L, Trush MA, Li Y. Free Radic Res; 2007 Feb 15; 41(2):242-50. PubMed ID: 17364951 [Abstract] [Full Text] [Related]
16. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells. Duechler M, Stańczyk M, Czyz M, Stepnik M. Cancer Chemother Pharmacol; 2008 Apr 15; 61(5):727-37. PubMed ID: 17594095 [Abstract] [Full Text] [Related]